Depression treatment does not always follow a straight line. Someone may try one antidepressant, switch medications, adjust the dose, add therapy, and still feel as though very little has changed. According to the National Institute of Mental Health, an estimated 21 million U.S. adults experienced a major depressive episode in 2021, representing about 8.3% of the adult population. Research published in The Journal of Clinical Psychiatry has also estimated that roughly 30.9% of adults receiving medication for major depressive disorder met criteria for treatment-resistant depression.
For people who reach that point, Spravato may become part of the conversation. Then another practical question usually comes up: how will treatment be paid for?
Fortunately, insurance coverage for Spravato is available through many health plans. That does not mean every policy approves it automatically. Coverage often depends on previous treatments, diagnosis, authorization requirements, and where care is provided.
Is Spravato Covered by Insurance?
Is Spravato covered by insurance? In many cases, it can be.
Spravato is an FDA-approved form of esketamine used for certain adults with treatment-resistant depression. Because it is given in a supervised healthcare setting rather than taken home like a standard prescription, insurance billing can look a little different.
Some plans process Spravato through the pharmacy benefit. Others handle part or all of the treatment through the medical benefit.
That distinction can affect prior authorization, copays, coinsurance, and the patient’s final pocket cost.
Before assuming a plan includes treatment, it helps to verify the actual benefits attached to the policy. Two people may have the same insurance company but very different coverage because their employers, deductibles, networks, or plan designs are different.
What Insurance Companies Require
There is usually paperwork involved before treatment begins.
Insurance companies require documentation showing why Spravato is medically appropriate. For someone with treatment-resistant depression, that often means records of antidepressants that were previously tried, how long they were taken, the dosage, and whether symptoms improved.
The insurer may also request clinical notes supporting the diagnosis.
In many cases, prior authorization is required. The treatment center sends information to the insurance carrier, and a reviewer compares it with the plan’s medical-necessity guidelines.
Spravato also has special administration requirements. It must be provided in an appropriate healthcare setting under supervision because patients need observation after each dose.
A missing medication date or incomplete treatment record may sound minor, but it can hold up approval. Having an accurate medication history ready can make this part considerably easier.
Insurance Plans Accepted at Scottsdale
Scottsdale TMS works with several major health insurance providers, including Medicare, TRICARE, UnitedHealthcare, Humana, Cigna, Blue Cross Blue Shield, and Aetna. Self-pay options may also be available.
Still, “accepted insurance” and “covered treatment” are not quite the same thing.
One Aetna plan, for example, may have different requirements from another Aetna policy. The same is true for Medicare Advantage plans and employer-based health plans.
When checking insurance coverage for Spravato, ask a few specific questions. Is the clinic in network? Does the plan require authorization? Is Spravato billed through the medical or pharmacy benefit? What deductible or coinsurance remains?
Those answers are far more useful than simply knowing the name of the insurance carrier.
What Happens During the Review Process?
Once the information is submitted, the insurance company reviews the request.
The reviewer may look at the diagnosis, earlier antidepressant trials, treatment dates, clinical notes, and the proposed treatment setting. Sometimes everything needed is already there, and a decision follows. Other times, the insurer asks for another document or sends the case for additional review.
That can feel discouraging when someone is already eager to begin treatment.
But a request for more information is not necessarily a denial. It may mean the file needs one missing detail before the insurer can determine whether the plan includes the requested care.
Keeping pharmacy records, medication names, and previous treatment information organized can help reduce delays during the review process.
What to Do if Insurance Denies Coverage?
Receiving a denial does not always close the door.
The first useful step is finding out why the request was denied. Maybe a document was missing. Perhaps the insurer requires evidence of another medication trial. In some cases, the problem is related to network rules rather than Spravato itself.
Once the reason is clear, the care team may be able to provide additional records, request reconsideration, arrange a peer-to-peer review, or help with an appeal.
Manufacturer financial support may also be available for some commercially insured patients who meet eligibility rules.
The good news is that a denial gives both the patient and provider something concrete to investigate. Rather than starting over, the next step can focus on the specific issue the insurer identified.
First Step at Scottsdale TMS
At Scottsdale TMS, insurance is only one piece of the treatment decision.
For some people with treatment-resistant depression, Spravato may be worth discussing. For others, TMS therapy may be a better fit. TMS uses focused magnetic pulses to stimulate areas of the brain associated with mood and does not require anesthesia or daily antidepressant medication during the session.
The team can review treatment history, discuss whether TMS makes clinical sense, and check insurance benefits before therapy begins.
That matters because the goal is not simply to find whatever treatment an insurance plan will approve. It is to understand the available options and choose care that fits the person’s symptoms, history, and needs.
If Spravato or TMS therapy is being considered, Scottsdale TMS can help clarify benefits, authorization requirements, and expected costs before the next step is taken.